Drouet, FR
Celine Drouet, Casson FR
Patent application number | Description | Published |
---|---|---|
20150183497 | METHOD FOR PREDICTING AT LEAST ONE MOVEMENT OF A SHIP UNDER THE EFFECT OF THE WAVES - The method consists of: A step of estimating a direction (D) of propagation of the swell and a propagation speed of the swell, a step of measuring the development of a characteristic value of the swell at at least one measuring point (P) upstream of the ship in the direction of propagation (D) by periodically measuring the value, a step of detecting a lull in the swell at the measuring point (P) using a measurement of the development of the characteristic value, including a measurement of a duration of a lull detected, and if a lull in the swell is detected at the measuring point (P): a step of calculating a time interval between the detection of the lull in the swell at the detected measurement point (P) and a moment in which the lull affects the movement of the ship (N), carried out, in particular, depending on the estimated speed of propagation of the swell. | 07-02-2015 |
Christian Drouet, Meylan FR
Patent application number | Description | Published |
---|---|---|
20140051099 | DIAGNOSIS AND TREATMENT OF ANGIOEDEMA - The present patent application relates to a method for diagnosing angioedema with a gain-of-function mutation of kinin formation, and for determining the amount of BK or des-Arg | 02-20-2014 |
20140315232 | METHOD FOR DOSING THE CONTROL CAPACITY OF C1INH - The present invention relates to a method for dosing the control capacity of plasma serpin (SERine Protease INhibitor) C1 inhibitor (C1Inh) on the basis of a patient blood sample. The invention also relates to a kit specially designed for said dosing. | 10-23-2014 |
Emmanuel Drouet, Grenoble Cedex 9 FR
Patent application number | Description | Published |
---|---|---|
20110311551 | ANTIBODIES DIRECTED AGAINST HEPATITIS C VIRUS E1E2 COMPLEX, COMPOSITIONS OF HCV PARTICLES, AND PHARMACEUTICAL COMPOSITIONS - The invention provides new conformational antibodies, and more particular conformational monoclonal antibodies and fragments thereof, that are directed against HCV. Also provided are compositions of particles that are recognized by such antibodies, and pharmaceutical compositions containing these particles. Also described are HCV enveloped subviral particles and purified HCV enveloped complete viral particles, as well as processes for their preparation. | 12-22-2011 |
20150239959 | Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions - Antibodies and antigen-binding molecules directed against Hepatitis C virus (HCV) are presented. The antibodies and antigen-binding molecules specifically bind to the HCV E1E2 complex. Also provided are pharmaceutical compositions containing the antibodies and/or antigen-binding molecules. Nucleic acids encoding the antibodies and antigen-binding molecules, along with corresponding expression vectors and host cells are also provided. | 08-27-2015 |
Emmanuel Drouet, Corenc FR
Patent application number | Description | Published |
---|---|---|
20100144014 | METHOD FOR AMPLIFYING HCV IN AEDES MOSQUITOES - A process for amplifying hepatitis C virus (HCV) in vivo is provided. The method includes ingesting | 06-10-2010 |
20110076671 | USE OF SYNTHETIC PEPTIDE DERIVED FROM ZEBRA PROTEIN FOR THE IN VITRO DIAGNOSIS OF THE EPSTEIN-BARR VIRUS (EBV) REACTIVATION - Method of using polypeptide derived from ZEBRA protein, or variants or isoforms of the polypeptide for the in vitro and ex vivo screening of the EBV virus reactivation in a biological sample of a subject afflicted by a pathology associated with EBV infection. | 03-31-2011 |
20110091969 | MUTATIONS IN THE NS5B PROTEIN OF THE HCV - An NS5B protein of the hepatitis C virus (HCV), with good replication performance, has a point mutation in at least one of the following positions: | 04-21-2011 |
20140342349 | USE OF AT LEAST ONE BIOMARKER FOR THE IN VITRO PROGNOSIS OR DIAGNOSIS OF LYMPHOPROLIFERATIVE EPISODES ASSOCIATED WITH THE EPSTEIN-BARR VIRUS (EBV) - A protein complex isolated from its natural medium and including the ZEBRA protein of sequence SEQ ID NO: 1, the isolated protein complex having the following properties: | 11-20-2014 |
Emmanuel Drouet, Grenoble Cedex FR
Patent application number | Description | Published |
---|---|---|
20130052187 | Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions - New conformational antibodies, and more particular conformational monoclonal antibodies and fragments thereof, are directed against HCV. Also provided are compositions of particles that are recognized by such antibodies, and pharmaceutical compositions containing these particles. Also described are HCV enveloped subviral particles and purified HCV enveloped complete viral particles, as well as processes for their preparation. | 02-28-2013 |
Florence Drouet, Bures Sur Yvette FR
Patent application number | Description | Published |
---|---|---|
20150204797 | METHOD AND DEVICE FOR DETECTING, IN PARTICULAR, REFRACTING DEFECTS - An in-line method for optically inspecting transparent or translucent containers ( | 07-23-2015 |
Francois X. Drouet, La Gaude FR
Patent application number | Description | Published |
---|---|---|
20150356067 | METHOD AND SYSTEM FOR EASILY AND SECURELY MANAGING MULTIPLE KEYS USED TO HAVE ACCESS TO MULTIPLE COMPUTING RESOURCES - The present invention is directed to a system, method and computer program for easily and securely managing multiple keys on a computer, each key being used to access one or a plurality of computing resources. The method comprises the steps of receiving a command for selecting a key among one or plurality of keys, each key comprising one or a plurality of key fields; receiving a command for activating a computing resource corresponding to the selected key in order to have access to the computing resource; retrieving and displaying on a computer screen, the one or plurality of key fields associated with the selected key; displaying on the computer screen one or a plurality of input fields, each input field being used to enter the content of an appropriate key field associated with the key selected to access the activated computing resource; passing, in response to an action of a pointing device on a displayed key field, the content of the key field in an appropriate input field of the activated computing resource; and having access to the activated computing resource when all key fields of the selected key have been passed to the appropriate input fields. | 12-10-2015 |
Francois-Xavier Drouet, Le Flore Cap Fabron FR
Patent application number | Description | Published |
---|---|---|
20090119387 | SYSTEM OF HANDLING A WEB SERVICE CALL - A system for handling a web service call by clients in a communication network is disclosed. The system comprises a client requester for issuing client requests. The client requests may comprise at least one client request to call a web service. The system also comprises a callback web Service that is coupled to the client requester for registering the at least one client request to call a web service and for invoking the called web service. A response web service is coupled to the callback web service for receiving a response to the at least one client request to call a web service and is also coupled to the client requester for delivering the response when a client request to obtain the response is issued from the client requester. | 05-07-2009 |
Karine Drouet, Acheres FR
Patent application number | Description | Published |
---|---|---|
20100065497 | MEMBRANE STATION WASTE TREATMENT PROCESS - A method of removing phosphonates from water includes directing the water into a first settling zone. The water is then directed to a membrane filtration zone and is filtered therein to produce a concentrate containing phosphonates. The concentrate containing phosphonates is then contacted with sludge such that at least some of the phosphonates in the concentrate are adsorbed onto the sludge. Flocculant is added to the sludge and the concentrate to form a floc-mixture which is directed to a second settling zone to form treated concentrate. | 03-18-2010 |
20110062081 | Process for Treating Waste From a Membrane Filtration Plant - The subject of the invention is a water treatment process, comprising a first pretreatment step that produces pretreated water and sludge, said pretreated water then undergoing at least one membrane filtration step that produces waste and a permeate, said permeate being conveyed to a potabilization system characterized in that said first pretreatment step comprises a first coagulation/flocculation step, and in that said waste resulting from said membrane filtration step undergoes a treatment phase that includes at least one second coagulation/flocculation step followed by a settling step that produces sludge, said settling step being preceded by at least one step of adsorption onto at least one portion of said sludge resulting from the pretreatment and/or onto a portion of said sludge originating from said settling step, said adsorption step targeting a reduction of the phosphonates contained in said waste resulting from said membrane filtration step, said process resulting in treated waste and in excess sludge. | 03-17-2011 |
Marie-Therese Drouet, Plaisir FR
Patent application number | Description | Published |
---|---|---|
20100099854 | NEUROVIRULENT STRAIN OF THE WEST NILE VIRUS AND USES THEREOF - Neuroinvasive and neurovirulent strain of the West Nile virus, named IS-98-ST1, nucleic acid molecules derived from its genome, proteins and peptides encoded by said nucleic acid molecules, and uses thereof. | 04-22-2010 |
Marie-Therese Drouet, Paris FR
Patent application number | Description | Published |
---|---|---|
20140237631 | Neurovirulent Strain of the West Nile Virus and Uses Thereof - Neuroinvasive and neurovirulent strain of the West Nile virus, named IS-98-ST1, nucleic acid molecules derived from its genome, proteins and peptides encoded by said nucleic acid molecules, and uses thereof. | 08-21-2014 |
Marie-Thérèse Drouet, Plaisir FR
Patent application number | Description | Published |
---|---|---|
20120266261 | NEUROVIRULENT STRAIN OF THE WEST NILE VIRUS AND USES THEREOF - Neuroinvasive and neurovirulent strain of the West Nile virus, named IS-98-ST1, nucleic acid molecules derived from its genome, proteins and peptides encoded by said nucleic acid molecules, and uses thereof. | 10-18-2012 |
Samuel Drouet, Cerences FR
Patent application number | Description | Published |
---|---|---|
20150096899 | IRON-BASED CATALYST FOR SELECTIVE ELECTROCHEMICAL REDUCTION OF CO2 INTO CO - The present invention relates to catalysts for the production of CO gas through electrochemical CO | 04-09-2015 |
Serge Drouet, Montanay FR
Patent application number | Description | Published |
---|---|---|
20090088595 | Process for producing propylene in the presence of a macroporous catalyst in the form of spherical beads - A process for once-through conversion of a hydrocarbon feed comprising at least olefins containing 4 carbon atoms and at least olefins containing 5 carbon atoms is described for the production of propylene, said process comprising passing said feed into at least one reaction unit provided with at least one catalyst in the form of spherical beads with a diameter in the range 1 to 3 mm, each of said spherical beads comprising at least one zeolite and at least one alumina-based support and having a pore distribution such that the macroporous volume, measured by mercury porosimetry, is in the range 0.10 to 0.20 ml/g and the mesoporous volume, measured by mercury porosimetry, is in the range 0.25 to 0.35 ml/g. | 04-02-2009 |
Yannick Drouet, Beaucroissant FR
Patent application number | Description | Published |
---|---|---|
20100209863 | RING FURNACE INCLUDING BAKING PITS WITH A LARGE HORIZONTAL ASPECT RATIO AND METHOD OF BAKING CARBONACEOUS ARTICLES THEREIN - The invention relates to a ring furnace ( | 08-19-2010 |